PEDIATRICS Vol. 9 No. 6 June 1952, pp. 722-728
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BRUTON, O. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BRUTON, O. C.

AGAMMAGLOBULINEMIA

OGDEN C. BRUTON M.C., U.S.A.1

1 The Pediatric Section, Medical Service, Walter Reed Army Hospital, Washington, D.C.

A hitherto unrecognized entity manifested by complete absence of gamma globulin with otherwise normal serum proteins and recurrent pneumococcal sepsis is described in an 8 year old male. The patient appears to be normal in other respects and after extensive study no structural or functional change could be demonstrated in any body system although gamma globulin by electrophoretic analysis of his serum was consistently absent. He was unable to produce antibody for the pneumococcus with the four antigenic substances used; a positive Schick test persisted in spite of numerous attempts to reverse it with diphtheria toxoid. No antibody could be demonstrated following administration of typhoid vaccine in the usual manner and his serum was negative for complement-fixing antibodies of epidemic parotitis after he experienced a typical clinical picture of that disease.

Gamma globulin could be demonstrated in his serum after concentrated immune human serum globulin was administered subcutaneously, and its gradual disappearance could be followed by electrophoretic analysis over a period of approximately six weeks. Concurrently, and following the administration of human globulin (3.2 gm. gamma globulin) at monthly intervals, he has been free of pneumococcal sepsis for more than a year, whereas he had experienced clinical sepsis at least 19 times in the previous four years in which eight different types of pneumococci had been recovered from blood culture during 10 different episodes.

It is postulated that by some acquired "influence" the patient's antibody mechanism has been altered so that he is no longer able to synthesize and/or hold antibody to a specific organism. A complete defect of plasma proteins cannot be excluded.

Submitted on February 25, 1952




This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
R Herriot and W A C Sewell
Antibody deficiency
J. Clin. Pathol., September 1, 2008; 61(9): 994 - 1000.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. W. LeBien and T. F. Tedder
B lymphocytes: how they develop and function
Blood, September 1, 2008; 112(5): 1570 - 1580.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
O. Levy
Bruton tyrosine kinase (Btk): key for signaling via Toll-like receptor 8
Blood, March 15, 2007; 109(6): 2273 - 2274.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Trivedi, S. C. Zhang, A. B. Castoreno, W. Stockinger, E. C. Shieh, J. M. Vyas, E.-M. Frickel, and A. Nohturfft
Immunoglobulin G signaling activates lysosome/phagosome docking
PNAS, November 28, 2006; 103(48): 18226 - 18231.
[Abstract] [Full Text] [PDF]

Home page
 Epidemiol RevHome page
J. D. Grabenstein, P. R. Pittman, J. T. Greenwood, and R. J.M. Engler
Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects
Epidemiol. Rev., August 1, 2006; 28(1): 3 - 26.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Warnatz, L. Bossaller, U. Salzer, A. Skrabl-Baumgartner, W. Schwinger, M. van der Burg, J. J. M. van Dongen, M. Orlowska-Volk, R. Knoth, A. Durandy, et al.
Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency
Blood, April 15, 2006; 107(8): 3045 - 3052.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
S. Shah
Pharmacy considerations for the use of IGIV therapy
Am. J. Health Syst. Pharm., August 15, 2005; 62(16_Supplement_3): S5 - S11.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
J.-L. Casanova and L. Abel
Inborn errors of immunity to infection: the rule rather than the exception
J. Exp. Med., July 18, 2005; 202(2): 197 - 201.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
B Seymour, J Miles, and M Haeney
Primary antibody deficiency and diagnostic delay
J. Clin. Pathol., May 1, 2005; 58(5): 546 - 547.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. W. Yu, R. S. Tabuchi, R. M. Kato, A. Astrakhan, S. Humblet-Baron, K. Kipp, K. Chae, W. Ellmeier, O. N. Witte, and D. J. Rawlings
Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer
Blood, September 1, 2004; 104(5): 1281 - 1290.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
M. S. Lim and K. S.J. Elenitoba-Johnson
The Molecular Pathology of Primary Immunodeficiencies
J. Mol. Diagn., May 1, 2004; 6(2): 59 - 83.
[Full Text] [PDF]

Home page
 ASH Education BookHome page
M. D. Cooper, L. L. Lanier, M. E. Conley, and J. M. Puck
Immunodeficiency Disorders
Hematology, January 1, 2003; 2003(1): 314 - 330.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
V. G. Hemming
Use of Intravenous Immunoglobulins for Prophylaxis or Treatment of Infectious Diseases
Clin. Vaccine Immunol., September 1, 2001; 8(5): 859 - 863.
[Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
H. W. Eijkhout, J. W.M. van der Meer, C. G.M. Kallenberg, R. S. Weening, J. T. van Dissel, L. A.M. Sanders, P. F.W. Strengers, H. Nienhuis, P. Th.A. Schellekens, and for the Inter-University Working Party for the Stu
The Effect of Two Different Dosages of Intravenous Immunoglobulin on the Incidence of Recurrent Infections in Patients with Primary Hypogammaglobulinemia: A Randomized, Double-Blind, Multicenter Crossover Trial
Ann Intern Med, August 7, 2001; 135(3): 165 - 174.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
E. Zi Yin, D. P. Frush, L. F. Donnelly, and R. H. Buckley
Primary Immunodeficiency Disorders in Pediatric Patients: Clinical Features and Imaging Findings
Am. J. Roentgenol., June 1, 2001; 176(6): 1541 - 1552.
[Full Text] [PDF]

Home page
 Int ImmunolHome page
T. Kouro, K. Nagata, S. Takaki, S. Nisitani, M. Hirano, M. I. Wahl, O. N. Witte, H. Karasuyama, and K. Takatsu
Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition
Int. Immunol., April 1, 2001; 13(4): 485 - 493.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Kumanogoh, X. Wang, I. Lee, C. Watanabe, M. Kamanaka, W. Shi, K. Yoshida, T. Sato, S. Habu, M. Itoh, et al.
Increased T Cell Autoreactivity in the Absence of CD40-CD40 Ligand Interactions: A Role of CD40 in Regulatory T Cell Development
J. Immunol., January 1, 2001; 166(1): 353 - 360.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. H. Buckley
Primary Immunodeficiency Diseases Due to Defects in Lymphocytes
N. Engl. J. Med., November 2, 2000; 343(18): 1313 - 1324.
[Full Text] [PDF]

Home page
 J. Virol.Home page
P. P. Sanna and D. R. Burton
Role of Antibodies in Controlling Viral Disease: Lessons from Experiments of Nature and Gene Knockouts
J. Virol., November 1, 2000; 74(21): 9813 - 9817.
[Full Text]

Home page
 J. Gen. Virol.Home page
B. Schlereth, P.-G. Germann,, V. ter Meulen, and S. Niewiesk
DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection
J. Gen. Virol., May 1, 2000; 81(5): 1321 - 1325.
[Abstract] [Full Text]

Home page
 J. Clin. Pathol.Home page
A. M Jones and H. B Gaspar
Immunogenetics: changing the face of immunodeficiency
J. Clin. Pathol., January 1, 2000; 53(1): 60 - 65.
[Full Text] [PDF]

Home page
 PediatricsHome page
C. W. Callahan, J. W. Bass, D. A. Person, and J. E. Shira
History of Military Pediatrics: Fifty Years of Training and Deploying Uniformed Pediatricians
Pediatrics, June 1, 1999; 103(6): 1298 - 1303.
[Full Text]

Home page
 CVIHome page
A. S. Goldman, S. E. Miles, H. E. Rudloff, K. H. Palkowetz, and F. C. Schmalstieg Jr.
Immunodeficiency Due to a Unique Protracted Developmental Delay in the B-Cell Lineage
Clin. Vaccine Immunol., March 1, 1999; 6(2): 161 - 167.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
H. Suzuki, Y. Terauchi, M. Fujiwara, S. Aizawa, Y. Yazaki, T. Kadowaki, and S. Koyasu
Xid-Like Immunodeficiency in Mice with Disruption of the p85 Subunit of Phosphoinositide 3-Kinase
Science, January 15, 1999; 283(5400): 390 - 392.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child.Home page
J Gaspar, B Gerritsen, and A Jones
Immunoglobulin replacement treatment by rapid subcutaneous infusion
Arch. Dis. Child., July 1, 1998; 79(1): 48 - 51.
[Abstract] [Full Text]

Home page
 PediatricsHome page
H. A. Pearson
The Ever-changing Content of Pediatrics Over Fifty Years
Pediatrics, July 1, 1998; 102(1): 168 - 176.
[Full Text]

Home page
 PediatricsHome page
R. H. Buckley
Agammaglobulinemia, by Col. Ogden C. Bruton, MC, USA, Pediatrics, 1952;9:722-728
Pediatrics, July 1, 1998; 102(1): 213 - 215.
[Abstract] [Full Text]

Home page
 PediatricsHome page
E. Holinski-Feder, M. Weiss, O. Brandau, K. B. Jedele, B. Nore, C. M. Backesjo, M. Vihinen, S. R. Hubbard, B. H. Belohradsky, C.I. E. Smith, et al.
Mutation Screening of the BTK Gene in 56 Families With X-Linked Agammaglobulinemia (XLA): 47 Unique Mutations Without Correlation to Clinical Course
Pediatrics, February 1, 1998; 101(2): 276 - 284.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Futatani, T. Miyawaki, S. Tsukada, S. Hashimoto, T. Kunikata, S. Arai, M. Kurimoto, Y. Niida, H. Matsuoka, Y. Sakiyama, et al.
Deficient Expression of Bruton's Tyrosine Kinase in Monocytes From X-Linked Agammaglobulinemia as Evaluated by a Flow Cytometric Analysis and Its Clinical Application to Carrier Detection
Blood, January 15, 1998; 91(2): 595 - 602.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z. Li, M. I. Wahl, A. Eguinoa, L. R. Stephens, P. T. Hawkins, and O. N. Witte
Phosphatidylinositol 3-kinase-gamma activates Bruton's tyrosine kinase in concert with Src family kinases
PNAS, December 9, 1997; 94(25): 13820 - 13825.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. B. Satterthwaite, H. Cheroutre, W. N. Khan, P. Sideras, and O. N. Witte
Btk dosage determines sensitivity to B cell antigen receptor cross-linking
PNAS, November 25, 1997; 94(24): 13152 - 13157.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
J. C. Oeltjen, T. M. Malley, D. M. Muzny, W. Miller, R. A. Gibbs, and J. W. Belmont
Large-Scale Comparative Sequence Analysis of the Human and Murine Bruton's Tyrosine Kinase Loci Reveals Conserved Regulatory Domains
Genome Res., April 1, 1997; 7(4): 315 - 329.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. Manis and R. S. Schwartz
Agammaglobulinemia and Insights into B-Cell Differentiation
N. Engl. J. Med., November 14, 1996; 335(20): 1523 - 1525.
[Full Text]

Home page
 NEJMHome page
D. C. Saffran, O. Parolini, M. E. Fitch-Hilgenberg, D. J. Rawlings, D. Afar, O. N. Witte, and M. E. Conley
A Point Mutation in the SH2 Domain of Bruton's Tyrosine Kinase in Atypical X-Linked Agammaglobulinemia
N. Engl. J. Med., May 26, 1994; 330(21): 1488 - 1491.
[Full Text]

Home page
 NEJMHome page
R. H. Buckley
Assessing Inheritance of Agammaglobulinemia
N. Engl. J. Med., May 26, 1994; 330(21): 1526 - 1528.
[Full Text]

Home page
 CLIN PEDIATRHome page
V. A. Fulginiti
Immunologic Deficiency States: Basic Review of Mechanisms of Immunity
Clinical Pediatrics, April 1, 1969; 8(4): 216 - 224.
[Abstract] [PDF]

Home page
 ScienceHome page
M. D. Cooper, M. L. Schwartz, and R. A. Good
Restoration of Gamma Globulin Production in Agammaglobulinemic Chickens
Science, January 28, 1966; 151(3709): 471 - 473.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
R. V. CROWDER Jr., W. T. THOMPSON Jr., and H. G. KUPFER
Acquired Agammaglobulinemia with Multiple Allergies and Pernicious Anemia
Arch Intern Med, March 1, 1959; 103(3): 445 - 452.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
R. L. WALL
The Use of Serum Protein Electrophoresis in Clinical Medicine
Arch Intern Med, October 1, 1958; 102(4): 618 - 658.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
E. C. LEWIS II and H. E. BROWN Jr.
Agammaglobulinemia Associated with Pernicious Anemia and Diabetes Mellitus
Arch Intern Med, August 1, 1957; 100(2): 296 - 299.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
R. L. WALL and S. SASLAW
ADULT AGAMMAGLOBULINEMIA
Arch Intern Med, January 1, 1955; 95(1): 33 - 36.
[Abstract] [PDF]